Market Cap 2.18B
Revenue (ttm) 58.84M
Net Income (ttm) -463.66M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -788.00%
Debt to Equity Ratio 0.01
Volume 17,387,306
Avg Vol 22,000,566
Day's Range N/A - N/A
Shares Out 519.84M
Stochastic %K 9%
Beta 0.95
Analysts Sell
Price Target $7.00

Company Profile

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery in the United States. The company develops REC-994, which is in Phase 2 clinical trial to treat cerebral cavernous malformation; REC-2282, which is in Phase 2/3 clinical trial for the treatment of neurofibromatosis type 2; REC-4...

Industry: Biotechnology
Sector: Healthcare
Phone: 385 269 0203
Fax: 801 821 2872
Address:
41 South Rio Grande Street, Salt Lake City, United States
WallStreetBuyDip
WallStreetBuyDip Feb. 3 at 7:44 PM
Result summaries are very crucial to keep track of how the strategy is going. Here's track record showing the results for Small + Mid cap stocks. Will next trade $RXRX + $ADPT and more like I did for small + mid cap stocks when H% is low. Do you see why I only buy when H% is low? All include timestamps + buy fills for everything. The result speaks for itself.
0 · Reply
Zio_Fauss
Zio_Fauss Feb. 3 at 7:04 PM
$RXRX Pure speculation, nothing more. It’s dropping because the indices are dragging it down. At this point we’re basically on the floor. Now it’s up to the institutional investors to show what they actually intend to do, and whether they truly believe in this.
0 · Reply
WolfofKarachi
WolfofKarachi Feb. 3 at 7:03 PM
$RXRX Total carnage
0 · Reply
Zio_Fauss
Zio_Fauss Feb. 3 at 6:51 PM
$RXRX critical moment….
0 · Reply
Lh2838
Lh2838 Feb. 3 at 6:09 PM
$RXRX say when
0 · Reply
joeypignuts
joeypignuts Feb. 3 at 5:13 PM
$RXRX unbelievable.
0 · Reply
Spartangio
Spartangio Feb. 3 at 4:46 PM
$RXRX Tech selloff not safe from it Anyway from today ARK now own 37 mln shares +15%
1 · Reply
Brodman
Brodman Feb. 3 at 4:20 PM
$RXRX All HYPE...This will be $2 after earnings. No way they make it long term. The big guys will be out of this soon. They aren't going to stick around long and lose a ton...no way.
0 · Reply
Floridaorange
Floridaorange Feb. 3 at 3:06 PM
$IBRX $RXRX https://www.youtube.com/watch?v=jY7AUFpnQJQ
0 · Reply
Ga0Ga
Ga0Ga Feb. 3 at 2:53 PM
$RXRX 🙏🏻
0 · Reply
Latest News on RXRX
3 Small AI Plays to Buy for 2026

Dec 26, 2025, 1:28 PM EST - 5 weeks ago

3 Small AI Plays to Buy for 2026

ANET INOD


What's Happening With RXRX Stock?

Dec 18, 2025, 11:05 AM EST - 6 weeks ago

What's Happening With RXRX Stock?


Jim Cramer: This Health Care Stock Has Been 'Horrendous'

Dec 5, 2025, 8:19 AM EST - 2 months ago

Jim Cramer: This Health Care Stock Has Been 'Horrendous'


Recursion to Participate in Upcoming Investor Conferences

Nov 4, 2025, 8:00 AM EST - 3 months ago

Recursion to Participate in Upcoming Investor Conferences


Top 2 Health Care Stocks You May Want To Dump This Quarter

Jul 22, 2025, 7:02 AM EDT - 7 months ago

Top 2 Health Care Stocks You May Want To Dump This Quarter

MEDP


Recursion Pharmaceuticals: Looking For Entry Around Q1 Earnings

May 5, 2025, 4:02 AM EDT - 9 months ago

Recursion Pharmaceuticals: Looking For Entry Around Q1 Earnings


Recursion to Participate in Upcoming Investor Conference

Apr 1, 2025, 8:00 AM EDT - 11 months ago

Recursion to Participate in Upcoming Investor Conference


Altitude Lab Startups Raise $154M in Capital

Feb 18, 2025, 11:00 AM EST - 1 year ago

Altitude Lab Startups Raise $154M in Capital


WallStreetBuyDip
WallStreetBuyDip Feb. 3 at 7:44 PM
Result summaries are very crucial to keep track of how the strategy is going. Here's track record showing the results for Small + Mid cap stocks. Will next trade $RXRX + $ADPT and more like I did for small + mid cap stocks when H% is low. Do you see why I only buy when H% is low? All include timestamps + buy fills for everything. The result speaks for itself.
0 · Reply
Zio_Fauss
Zio_Fauss Feb. 3 at 7:04 PM
$RXRX Pure speculation, nothing more. It’s dropping because the indices are dragging it down. At this point we’re basically on the floor. Now it’s up to the institutional investors to show what they actually intend to do, and whether they truly believe in this.
0 · Reply
WolfofKarachi
WolfofKarachi Feb. 3 at 7:03 PM
$RXRX Total carnage
0 · Reply
Zio_Fauss
Zio_Fauss Feb. 3 at 6:51 PM
$RXRX critical moment….
0 · Reply
Lh2838
Lh2838 Feb. 3 at 6:09 PM
$RXRX say when
0 · Reply
joeypignuts
joeypignuts Feb. 3 at 5:13 PM
$RXRX unbelievable.
0 · Reply
Spartangio
Spartangio Feb. 3 at 4:46 PM
$RXRX Tech selloff not safe from it Anyway from today ARK now own 37 mln shares +15%
1 · Reply
Brodman
Brodman Feb. 3 at 4:20 PM
$RXRX All HYPE...This will be $2 after earnings. No way they make it long term. The big guys will be out of this soon. They aren't going to stick around long and lose a ton...no way.
0 · Reply
Floridaorange
Floridaorange Feb. 3 at 3:06 PM
$IBRX $RXRX https://www.youtube.com/watch?v=jY7AUFpnQJQ
0 · Reply
Ga0Ga
Ga0Ga Feb. 3 at 2:53 PM
$RXRX 🙏🏻
0 · Reply
Ryan071236
Ryan071236 Feb. 3 at 2:31 PM
$RXRX youve got 2 years until this plays out if ever. this will go to $2 after they dulute the shares end of 2027. after that it will depend on drugs and potential. dead money until then, or dead money flat out.
0 · Reply
Spartangio
Spartangio Feb. 3 at 2:14 PM
$RXRX Platform is working We will get the fruits soon imo and jpm imo https://x.com/recursionpharma/status/2018688437218402814?s=46&t=85a54NYUrIhXDU7SWgzM7Q
0 · Reply
theRockSeys
theRockSeys Feb. 3 at 6:14 AM
$RXRX lol 52 week low is when you buy not sell
0 · Reply
Tobitski
Tobitski Feb. 3 at 1:28 AM
$RXRX Nice day to buy 😅🍻 💣
0 · Reply
Ryan071236
Ryan071236 Feb. 3 at 12:24 AM
$RXRX sell this and get out of it asap its going down to $1-$2. this thing is horrendous….. short this turd
0 · Reply
Brodman
Brodman Feb. 2 at 11:02 PM
$RXRX Near the 52 week low...time to realize that this POS is all hype and zero substance!! Going lower!!!
0 · Reply
Zio_Fauss
Zio_Fauss Feb. 2 at 7:12 PM
$RXRX It’ll be a moment. It’ll be news. It’ll be a solid climb. It’ll be a short. Yes: it’ll be a short squeeze. Promised!!! 11 by JPM remember…!
0 · Reply
theRockSeys
theRockSeys Feb. 2 at 5:55 PM
$RXRX liking the bounce here. Seems that the data readout in December was worth buying shares from its all time low. Looking forward to more data in the future
1 · Reply
Brodman
Brodman Feb. 2 at 5:32 PM
$RXRX One 1 GREEN day and 4 RED isn't going to get it. This garbage will be at 52 week lows this month. Instead of hype, some actual results would help. I'm sure the big players are get pretty disenchanted with RXRX too....people will start jumping off the sinking ship soon.
1 · Reply
Zio_Fauss
Zio_Fauss Feb. 2 at 5:31 PM
$RXRX give me +24%!!!!
0 · Reply
Ga0Ga
Ga0Ga Feb. 2 at 3:54 PM
0 · Reply
Floridaorange
Floridaorange Feb. 2 at 3:03 PM
$RXRX Microglia are not just “another cell type.” They sit at the crossroads of: • Alzheimer’s • Parkinson’s • ALS • MS • Neuroinflammation broadly Historically: • Microglia were poorly understood • Tools were blunt • Targets were recycled → failure rates exploded What Recursion delivered: • A whole-genome, unbiased phenotypic map • Across microglial states, not just one condition • Generated via massive wet-lab experimentation + AI That’s not incremental. That’s a new discovery surface.
1 · Reply